ETF Managers Group, LLC Syros Pharmaceuticals, Inc. Transaction History

ETF Managers Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.01 - $7.48 $111,557 - $166,557	-22,267 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $51,652 - $107,400	-7,184 Reduced 24.39%	22,267 $161,000
Q4 2020 Feb 16, 2021	SELL	$6.66 - $14.66 $57,156 - $125,812	-8,582 Reduced 22.56%	29,451 $350,000
Q3 2020 Nov 16, 2020	BUY	$8.69 - $14.47 $330,506 - $550,337	38,033 New	38,033 $364,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.25M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.